A recall of 0.083% Albuterol Sulfate Inhalation Solution was issued by The Ritedose Corporation. The products affected are 3 mL in 25, 30 and 60 single dose vials. Dosages listed on the foil overwrap pouches and shelf cartons are correct, but the amounts printed on the vials are not. The vials are labeled as 0.5 mg/3 mL but contain 2.5 mg/3 mL doses. Improper dosing of the medication can lead to many health effects, ranging from temporary and treatable to death. The products were distributed nationwide and in Puerto Rico.
Lot numbers manufactured by the Ritedose Corporation under NDC: 0591-3797-83, 0591-3797-30 and 0591-3797-60 are included in the recall: 0N81, 0N82, 0N83, 0N84, 0NE7, 0NE8, 0NE9, 0NF0, 0P12, 0P13, 0P46, 0P47, 0PF0, and 0S15. Individuals with the affected vials should return them to the location they were obtained (i.e. physician’s office, pharmacy, etc.).
Special concern is being paid to hospitals where medication is often separate from its packaging. Health care professionals in that setting could increase normal dosage due to the incorrect information on the vial administering about five times the necessary amount. Significant overdosing could cause albuterol toxicity. Signs and symptoms of albuterol toxicity include dizziness, headache, seizures, high blood pressure, tremors, low potassium levels, angina and rapid heart rates.
Messa & Associates has successfully litigated cases for plaintiffs dealing with albuterol injuries in the past. If you or a loved one has suffered injuries as a result of albuterol toxicity, please contact us at 1-877-MessaLaw.
No comments:
Post a Comment